Screening for Early Gastric Cancer in Shaanxi Province
Launched by SECOND AFFILIATED HOSPITAL OF XI'AN JIAOTONG UNIVERSITY · Mar 13, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called "Screening for Early Gastric Cancer in Shaanxi Province," is focused on identifying early signs of stomach cancer among local residents aged 20 and older. The study aims to gather important health information by having participants fill out questionnaires and undergo a simple blood test to check for Helicobacter pylori, a bacteria linked to stomach problems. Researchers will evaluate this data to find people at higher risk for gastric cancer and offer them a procedure called electronic gastroscopy, which allows doctors to look inside the stomach for any early signs of cancer or related conditions.
To participate, you need to be a local resident over 20 years old and willing to give your consent to join the study. If you choose to participate, you will complete a questionnaire and provide a blood sample. The study is currently recruiting participants, and your involvement will help researchers understand how common stomach issues are in the area and improve future screening for gastric cancer. It's a chance to contribute to important health research while also getting valuable information about your own health.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Local resident over 20 years old.
- • Obtain verbal informed consent of the subject.
- Exclusion Criteria:
- • Refused to participate in this research project.
- • Questionnaires or serological tests for helicobacter pylori antibodies were not completed.
- • This study was not completed due to other reasons.
About Second Affiliated Hospital Of Xi'an Jiaotong University
The Second Affiliated Hospital of Xi'an Jiaotong University is a leading medical institution in China, dedicated to advancing healthcare through innovative clinical research and patient care. Affiliated with one of the country's premier universities, the hospital combines clinical excellence with academic rigor, fostering a multidisciplinary approach to healthcare challenges. With a strong emphasis on patient-centered care, the hospital engages in a wide range of clinical trials aimed at improving treatment outcomes and enhancing medical knowledge. Its commitment to ethical standards and regulatory compliance ensures that all research initiatives prioritize patient safety and scientific integrity.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Xi'an, Shaanxi, China
Patients applied
Trial Officials
jinhai Wang, MD
Study Director
Second Affilated Hospital of Xi'an Jiaotong University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials